Recent advances in bioaffinity strategies for preclinical and clinical drug discovery: Screening natural products, small molecules and antibodies

Drug Discov Today. 2024 Jan 24;29(3):103885. doi: 10.1016/j.drudis.2024.103885. Online ahead of print.ABSTRACTBioaffinity drug screening strategies have gained popularity in preclinical and clinical drug discovery for natural products, small molecules and antibodies owing to their superior selectivity, the large number of compounds to be screened and their ability to minimize the time and expenses of the drug discovery process. This paper provides a systematic summary of the principles of commonly used bioaffinity-based screening methods, elaborates on the success of bioaffinity in clinical drug development and summarizes the active compounds, preclinical drugs and marketed drugs obtained through affinity screening methods. Owing to the high demand for new drugs, bioaffinity-guided screening techniques will play a greater part in clinical drug development.PMID:38278476 | DOI:10.1016/j.drudis.2024.103885
Source: Drug Discovery Today - Category: Drugs & Pharmacology Authors: Source Type: research